Sinocelltech Group (SHSE:688520) EV-to-EBIT : -411.17 (As of May. 18, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sinocelltech Group's Enterprise Value is ¥23,365 Mil. Sinocelltech Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-57 Mil. Therefore, Sinocelltech Group's EV-to-EBIT for today is -411.17.

The historical rank and industry rank for Sinocelltech Group's EV-to-EBIT or its related term are showing as below:

SHSE:688520' s EV-to-EBIT Range Over the Past 10 Years
Min: -425.61 Med: -36.48 Max: -21.43
Current: -411.17

During the past 8 years, the highest EV-to-EBIT of Sinocelltech Group was -21.43. The lowest was -425.61. And the median was -36.48.

SHSE:688520's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.22 vs SHSE:688520: -411.17

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sinocelltech Group's Enterprise Value for the quarter that ended in Mar. 2024 was ¥20,687 Mil. Sinocelltech Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-57 Mil. Sinocelltech Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -0.27%.

Sinocelltech Group EV-to-EBIT Historical Data

The historical data trend for Sinocelltech Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group EV-to-EBIT Chart

Sinocelltech Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-27.98

-31.34

-63.51

-92.66

Sinocelltech Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-66.35	-88.05	-113.84	-92.66	-364.05

Competitive Comparison of Sinocelltech Group's EV-to-EBIT

For the Biotechnology subindustry, Sinocelltech Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinocelltech Group's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinocelltech Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sinocelltech Group's EV-to-EBIT falls into.

Sinocelltech Group EV-to-EBIT Calculation

Sinocelltech Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	23365.365	/	-56.826
	=	-411.17

Sinocelltech Group's current Enterprise Value is ¥23,365 Mil.
Sinocelltech Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-57 Mil.

Sinocelltech Group (SHSE:688520) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sinocelltech Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-56.826	/	20687.22164
	=	-0.27 %

Sinocelltech Group's Enterprise Value for the quarter that ended in Mar. 2024 was ¥20,687 Mil.
Sinocelltech Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-57 Mil.

Sinocelltech Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinocelltech Group (SHSE:688520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176

Website

http://www.sinocelltech.com

Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

Sinocelltech Group (SHSE:688520) Headlines

No Headlines